CADENCE PHARMA CONSULTANTS LIMITED - MANCHESTER
Company Profile | Company Filings |
Overview
CADENCE PHARMA CONSULTANTS LIMITED is a Private Limited Company from MANCHESTER UNITED KINGDOM and has the status: Active.
CADENCE PHARMA CONSULTANTS LIMITED was incorporated 9 years ago on 23/02/2015 and has the registered number: 09452984. The accounts status is DORMANT and accounts are next due on 31/12/2024.
CADENCE PHARMA CONSULTANTS LIMITED was incorporated 9 years ago on 23/02/2015 and has the registered number: 09452984. The accounts status is DORMANT and accounts are next due on 31/12/2024.
CADENCE PHARMA CONSULTANTS LIMITED - MANCHESTER
This company is listed in the following categories:
74909 - Other professional, scientific and technical activities n.e.c.
74909 - Other professional, scientific and technical activities n.e.c.
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 3 | 31/03/2023 | 31/12/2024 |
Registered Office
15 HERITAGE GARDENS
MANCHESTER
M20 5HJ
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
23/02/2023 | 08/03/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
PROFESSOR JOHN LEONARD | Jul 1954 | British | Director | 2015-02-23 | CURRENT |
MS HAZEL ELIZEBETH JAMES | Dec 1960 | British | Director | 2015-02-23 | CURRENT |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Accounts Submission | 2024-01-02 | 31-03-2023 | £472 equity |
Accounts Submission | 2022-11-01 | 31-03-2022 | £972 equity |
Accounts Submission | 2021-10-30 | 31-03-2021 | £2,251 equity |
Accounts Submission | 2020-10-28 | 31-03-2020 | £465 equity |
Accounts Submission | 2019-10-31 | 31-03-2019 | £5,494 equity |
Accounts Submission | 2018-10-30 | 31-03-2018 | £7,572 equity |
Accounts Submission | 2017-08-31 | 31-03-2017 | £18,859 equity |
Accounts filed on 31-03-2016 | 2016-11-01 | 31-03-2016 | £25,472 equity |